AMICUS THERAPEUTICS, INC. — Director's Dealing 2023

Dec 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2023-12-01

Reporting Person: Campbell Bradley L (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-01	Common Stock	M	11702	$2.94	Acquired	803863	Direct
2023-12-01	Common Stock	S	11702	$11.0830	Disposed	792161	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-01	Stock Options (right to buy)	$2.94	M	11702	Disposed	2024-06-26	Common Stock (11702)	Direct

Footnotes

F1: This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.88 to $11.21 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: All of the options were fully vested and exercisable as of the transaction date.